Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes

Eileen Wedge; Henrik Sengeløv; Jakob Werner Hansen; Niels Smedegaard Andersen; Ida Schjødt; Søren Lykke Petersen; Brian Kornblit; Kirsten Grønbæk; Lone Smidstrup Friis

doi:10.1016/j.bbmt.2020.02.010

Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes

Eileen Wedge, Henrik Sengeløv, Jakob Werner Hansen, Niels Smedegaard Andersen, Ida Schjødt, Søren Lykke Petersen, Brian Kornblit, Kirsten Grønbæk, Lone Smidstrup Friis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

15 Citationer (Scopus)

21 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Biology of Blood and Marrow Transplantation
Vol/bind	26
Udgave nummer	6
Sider (fra-til)	1091-1098
ISSN	1083-8791
DOI	https://doi.org/10.1016/j.bbmt.2020.02.010
Status	Udgivet - 2020

Adgang til dokumentet

10.1016/j.bbmt.2020.02.010Licens: CC BY-NC-ND

FulltextForlagets udgivne version, 1,06 MBLicens: CC BY-NC-ND

OpenUrl tilgængelighed

Fuld tekst

Citationsformater

Wedge, E., Sengeløv, H., Hansen, J. W., Andersen, N. S., Schjødt, I., Petersen, S. L., Kornblit, B., Grønbæk, K., & Friis, L. S. (2020). Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation, 26(6), 1091-1098. https://doi.org/10.1016/j.bbmt.2020.02.010

Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes. / Wedge, Eileen; Sengeløv, Henrik; Hansen, Jakob Werner et al.
I: Biology of Blood and Marrow Transplantation, Bind 26, Nr. 6, 2020, s. 1091-1098.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wedge, E, Sengeløv, H, Hansen, JW, Andersen, NS, Schjødt, I, Petersen, SL, Kornblit, B, Grønbæk, K & Friis, LS 2020, 'Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes', Biology of Blood and Marrow Transplantation, bind 26, nr. 6, s. 1091-1098. https://doi.org/10.1016/j.bbmt.2020.02.010

@article{f26aed1ac15849ceb156b2b0eaa45d8c,

title = "Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes",

author = "Eileen Wedge and Henrik Sengel{\o}v and Hansen, {Jakob Werner} and Andersen, {Niels Smedegaard} and Ida Schj{\o}dt and Petersen, {S{\o}ren Lykke} and Brian Kornblit and Kirsten Gr{\o}nb{\ae}k and Friis, {Lone Smidstrup}",

year = "2020",

doi = "10.1016/j.bbmt.2020.02.010",

language = "English",

volume = "26",

pages = "1091--1098",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Improved Outcomes after Allogenic Hematopoietic Stem Cell Transplantation with Fludarabine/Treosulfan for Patients with Myelodysplastic Syndromes

AU - Wedge, Eileen

AU - Sengeløv, Henrik

AU - Hansen, Jakob Werner

AU - Andersen, Niels Smedegaard

AU - Schjødt, Ida

AU - Petersen, Søren Lykke

AU - Kornblit, Brian

AU - Grønbæk, Kirsten

AU - Friis, Lone Smidstrup

PY - 2020

Y1 - 2020

U2 - 10.1016/j.bbmt.2020.02.010

DO - 10.1016/j.bbmt.2020.02.010

M3 - Journal article

C2 - 32088368

SN - 1083-8791

VL - 26

SP - 1091

EP - 1098

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 6

ER -